Sopheon has been notified that certain directors of the Company have purchased shares in the Company.
Barry Mence has purchased 3,000 ordinary shares of 20 pence each in the capital of the Company (“Ordinary Shares”) in his Individual Savings Account (“ISA”). Barry Mence’s spouse Maria Mence has purchased 2,750 Ordinary Shares in her ISA. The above shares were purchased at a price of £3.97 each. In addition, Barry Mence has transferred 2,000 Ordinary Shares from being held in his Self Invested Personal Pension (“SIPP”) to his ISA, and he has also transferred 3,000 Ordinary Shares from being held in his SIPP to the ISA of Maria Mence. Barry Mence’s total beneficial interest in Ordinary Shares, including those held by his wife, has accordingly increased by 5,750 Ordinary Shares to 1,458,326 Ordinary Shares.
Stuart Silcock has purchased 625 Ordinary Shares in his dealing account. Stuart Silcock’s spouse Christine Silcock has purchased 1,250 Ordinary Shares in her dealing account and a further 625 Ordinary Shares in her ISA. The above shares were purchased at a price of £3.97 each. In addition, Stuart Silcock has transferred 7,000 Ordinary Shares from being held in his SIPP to his ISA. Stuart Silcock’s total beneficial interest in Ordinary Shares, including those of his wife, as well as his interest in Ordinary Shares held in Bare Trust for his grandchildren has accordingly increased by 2,500 Ordinary Shares to 279,627 Ordinary Shares.
For Further Information Contact:
| Barry Mence, Chairman Arif Karimjee, CFO |
Sopheon plc | + 44 (0) 1276 919 560 |
| Carl Holmes / Giles Rolls (corporate finance) Mia Gardener (corporate broking) |
finnCap | + 44 (0) 20 7220 0500 |
About Sopheon
Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon’s Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon’s solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange.
